Karen Schneck, PharmD

PK/PD/Pharmacometrics
Eli Lilly and Company, United States

Karen Schneck is a Global PK/PD/Pharmacometrics Senior Advisor at Eli Lilly. Karen holds a PharmD from SUNY Buffalo and a master’s in Pharmacometrics from the University of Maryland, and has many years of hands-on experience. She champions model-informed drug development by advocating for innovation and putting forward-thinking approaches into action.

Disclosure information not submitted.

Presentation(s):

• Differentiated MIDD strategies to accelerate clinical development in metabolic diseases are worth their weight

  Sunday, October 19, 2025
  11:00 AM - 12:30 PM MDT

• Pharmacokinetics of incretin mimetics: a forward-looking perspective

  Sunday, October 19, 2025
  11:00 AM - 11:22 AM MDT